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Abstract 
 “Paradoxical” embolization via intracardiac or intrapulmonary right-to-left shunts (RLS) is an 
established cause of stroke. Hypercoagulable states and increased right heart pressure, which 
both occur in SCA, predispose to paradoxical embolization. We hypothesized that children with 
SCA and overt stroke have an increased prevalence of potential RLS. We performed contrasted 
transthoracic echocardiograms on 147 children (ages 2-19y) with SCA and overt stroke 
(SCA+stroke; mean age 12.7±4.8 years, 54.4% male) and a control group without SCA or 
stroke (n=123; mean age 12.1±4.9 years, 53.3% male). RLS was defined as any potential RLS 
detected by any method, including intrapulmonary shunting.  Echocardiograms were masked 
and adjudicated centrally.  The prevalence of potential RLS was significantly higher in the 
SCA+stroke group than controls (45.6% vs. 23.6%, p<0.001). The odds ratio for potential RLS 
in the SCA+stroke group was 2.7 (95% confidence interval: 1.6-4.6) vs controls.  In post hoc 
analyses, the SCA+stroke group had a higher prevalence of intrapulmonary (23.8% vs. 5.7%, 
p<0.001) but not intracardiac shunting (21.8% vs. 18.7%, p=0.533). SCA patients with potential 
RLS were more likely to report headache at stroke onset than those without. Intrapulmonary and 
intracardiac shunting may be an overlooked, independent, and potentially modifiable risk factor 
for stroke in SCA.  
 
Introduction 
Children with sickle cell anemia (SCA) are at high risk of ischemic stroke, the causes of which 
are still not fully understood (Roach, et al., 2009).  This high risk must be driven, at least in part, 
by the adverse effects of sickle hemoglobin. Until recently, any additional role for the “traditional” 
risk factors for stroke (identified in the general population) has not been considered clinically or 
studied in children with SCA and stroke (Dowling, et al., 2009).  In children and young adults 
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without SCA, “paradoxical” embolization is an established cause of stroke.  By this mechanism, 
emboli from the venous circulation escape filtration by the lungs and pass from the right heart 
directly to the left heart and on to the brain (Overell, et al., 2000; Benedik, et al., 2007; Dowling 
and Ikemba, 2011; Ning, et al., 2013). Such right-to-left shunting (RLS) can occur via a patent 
foramen ovale (PFO), any other intracardiac shunt, or intrapulmonary shunts, such as 
pulmonary arteriovenous malformations.  The risk of paradoxical embolization is increased by 
hypercoagulable states and elevated right heart pressures, both of which may occur more often 
in children with SCA (Ning, et al., 2013; Hassell, 2005; Ataga and Orringer, 2003). 
In a pilot study, we found a higher prevalence of potential right-to-left shunting in children with 
SCA and stroke than in a comparison group of children without SCA who also had stroke 
(Dowling, et al., 2010).  There are few control data available on the prevalence of potential 
shunting in children without stroke (Dowling and Ikemba, 2011).  We sought to determine if 
paradoxical embolization could be a risk factor for stroke in children with SCA by evaluating a 
large population of children with SCA and stroke and a control group of children without SCA or 
stroke by standardized contrast echocardiographic methods in a prospective multicenter study.  
We hypothesized that the prevalence of potential right-to-left shunting detected by contrast 
transthoracic echocardiography would be higher in children with SCA and stroke than in a 
control population of children without SCA or stroke.   
Methods  
We performed a cross sectional study of children with a diagnosis of SCA [defined here as 
homozygous sickle cell anemia (HbSS) or sickle-β0-thalassemia] and a history of clinically overt 
ischemic stroke (acute or remote) as well as controls without SCA or history of stroke to 
evaluate for potential right-to-left shunting by contrasted transthoracic echocardiogram (TTE).  
Local Ethics or Institutional Review Board approval was obtained at all 14 institutions in the US 
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and UK (see Acknowledgements). We enrolled children 2-19 years of age who had intravenous 
(IV) access obtained for another clinical indication (e.g. blood transfusion, hydration, or 
administration of IV medication).  Informed consent, and assent when appropriate, was provided 
by all participants or their parents. 
We chose a control group of children without SCD and without history of stroke for reasons of 
feasibility, along with financial and ethical limitations.  Our Institutional Review Board would not 
permit placement of an intravenous line required for the administration of agitated saline 
contrast for the echocardiogram solely for the purposes of this study, where there was 
presumed to be no clinical benefit.  Thus, while children with SCD frequently receive 
venipuncture, we were not allowed to leave an IV in place for the study at the time of simple 
venipuncture.  There had to be another clinical indication for the IV to remain in place and the 
children had to be “healthy” at the time of the study. This precluded the study of shunting in 
children with SCA without overt stroke who were not acutely ill.  Thus, there were limited 
opportunities to enroll children with SCA without stroke in the study and we chose a control 
group of children without SCD or stroke who had an IV in place for another clinical indication.   
Within these parameters, we were able to enroll children with SCD and stroke on chronic 
transfusion programmes where the echocardiogram could be scheduled in advance in 
conjunction with planned transfusions for which an IV would be in place. For control subjects, 
the same requirements were in place.  Many of our control patients were drawn from 
populations scheduled for planned procedures, minor surgeries, imaging studies, or infusions 
that required planned placement of an IV.  
Further, clinically silent stroke is highly prevalent in children with SCA (DeBaun, et al., 2014) 
and this could be related to RLS as well. We felt that children with SCA would require screening 
for silent infarction for inclusion as control subjects.  Our study budget did not allow for MRI to 
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evaluate for the presence of silent cerebral infarction in the control group but this was assumed 
to be a low frequency event in our control group of children without SCA.   
We defined stroke as a focal neurologic deficit of acute onset with a corresponding abnormality 
on CT or MRI in a location consistent with the neurologic signs and symptoms.   Children with 
SCA and only silent cerebral infarctions (those identified only by imaging study without any 
corresponding focal neurologic abnormalities) were not included.  For control subjects we 
excluded those with known or suspected congenital heart disease and those undergoing 
echocardiogram for transient ischemic attack, migraine headache, or other neurologic 
indication.  Additionally we excluded patients who were clinically unstable for echocardiogram or 
had undergone surgical closure of any intracardiac shunts. 
Transthoracic echocardiograms were performed by standardized methods at the local sites and 
included conventional 2-D, color Doppler, and a total of 4 IV contrast injections with agitated 
saline, including 2 at rest and 2 with Valsalva maneuver.   For the contrast injections, peripheral 
IV or indwelling “ports” were used to administer agitated saline (5ml for patients <45 kg, 10 ml 
for patients >45 kg).  Images were recorded in a 4-chamber view by standard technique (Woods 
and Patel, 2006).  A minimum of 5 seconds recording was obtained to allow the contrast to 
reach the heart and ≥5 cardiac cycles were reviewed.  Potential right-to-left shunts were defined 
as the detection of any shunting, in any direction, by any method, including 2-D, color Doppler, 
or any one of the 4 contrast injections.  Intrapulmonary shunting, characterized by the detection 
of “late bubbles” (detection of contrast in the left atrium or ventricle 5 cardiac cycles after the 
appearance of contrast in the right heart) is also included as potential RLS.  Patient age, weight, 
height, heart rate, blood pressure and oxygen saturation by pulse oximetry were recorded at the 
time of the echocardiogram.   
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Echocardiograms were analyzed at the local site then de-identified for masked central review by 
the study cardiologist.  In the event of conflicts between local and central interpretations, the 
studies were re-reviewed with a third masked evaluator and consensus was obtained.  All 
echocardiograms where potential shunting was identified were re-reviewed to confirm and 
classify the potential shunting as intracardiac or intrapulmonary. 
Demographic as well as clinical history and laboratory data were collected by medical record 
review and patient/parent interview using standard case report forms.  Data were checked by 
dual entry techniques, with identification of outliers and query of the local sites.   
Based on published data and the results of our pilot study (Dowling and Ikemba, 2011; Dowling, 
et al., 2010) a minimum of 160 patients per arm (320 total) were needed to detect a prevalence 
of RLS estimated at 19.99% for SCA+stroke patients and 9% for controls assuming a Type I 
error of .05 and 80% power using a 2 sided, independent samples Z test for proportions; 
alternatively this same sample size estimate for chi-square resulted in 81.8% power.  We closed 
study enrollment when all eligible patients at the study sites had been enrolled or screened.  
Final study enrollment after exclusion of cases was 270 (see below).   
The prevalence of potential RLS in the two groups was compared using Chi-square or Fisher’s 
exact test, as appropriate. The clinical and demographic data obtained by review of the medical 
record and patient/parent questionnaires were analyzed for association with shunting using Chi-
square or Fisher’s exact test for categorical, and Student’s t-test or Mann-Whitney U test for 
continuous variables, as appropriate.  Subjects and controls were not matched by age, gender, 
or race.  Prior studies report that age is an important factor in the prevalence of patent foramen 
ovale but sex and race are not (Dowling and Ikemba, 2011).  We re-evaluated this with 
additional analyses that explored the influence of demographic features (group, sex, race, and 
age at echo) on the prevalence of potential shunting or pulmonary shunting using logistic 
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regression models.  The assumptions for all statistical analyses were examined for violations.  A 
p-value of <0.05 was considered significant for the primary and secondary analyses which were 
performed using IBM SPSS version 23.0. 
Results 
Characteristics of Participants 
We enrolled and evaluated 283 children. Thirteen participants were excluded from the analysis 
(8 with SCA+stroke and 5 controls) for inadequate echocardiogram or inadequate contrast 
studies.  Data from 147 children with SCA+stroke and 123 controls were analyzed.  There were 
no adverse events reported during the study echocardiograms. 
There were no significant differences in age or gender between the two groups, except the 
expected difference in racial distribution (Table 1).  Most children with SCA+stroke were 
enrolled several years after their initial stroke; mean age at stroke was 6.2 years with 
echocardiogram performed at a mean age of 12.7 years. 
Frequency of Potential Right-to-Left Shunting 
There was a significantly higher prevalence of potential shunting in the SCA+stroke group 
(45.6% vs. 23.6% in controls p<0.001, Table 2). Contrast injection increased the detection rate 
for potential shunting in both groups, but the addition of Valsalva maneuver had minimal effect. 
There was a higher prevalence of intrapulmonary shunting (“late bubbles” only) in the 
SCA+stroke group (23.8% vs. 5.7% in controls, p<0.001) but not intracardiac shunting (21.8% 
vs. 18.7%, p=0.533). 
Risk Factors for Potential Right-to-Left Shunting  
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Logistic regression analyses demonstrated that age at echocardiogram and sex were not 
significant predictors of any potential shunting when both groups were included in the analysis 
(p>0.6) or of intrapulmonary shunting when the SCA/stroke group was included in the analysis 
(p>0.5).  Race (Black vs. White) was not a predictor of potential shunting when the control 
group was included in the analysis (p>0.4).  In the final model predicting any potential shunting, 
only group (SCA+stroke vs. controls) was predictive for the presence of any potential shunting.  
Those with any potential shunting were 2.7 times more likely to be in the SCA/stroke group 
compared to Controls than those without any potential shunting [odds ratio (OR) = 2.7; 95% 
confidence interval (CI), 1.6-4.6]. 
Clinical Correlates of Stroke in Participants with Potential RLS 
We also compared the demographic, clinical, and laboratory data of the SCA+stroke group with 
and without potential RLS (Table 3).  Headache was reported at the time of onset of stroke in 
48% of those with shunting vs. 27% of those without (p=0.021). There were no other significant 
differences between those SCA+stroke patients with and without RLS.  There was no difference 
in patient-reported ongoing “bad headaches or migraine” at the time of the echocardiogram 
(p=0.888).  There also was no difference in the prevalence of recurrent stroke or TIA between 
those with and without shunting.   
We studied these same demographic, clinical, and laboratory data in the SCA+stroke group with 
and without intrapulmonary shunting only. There was a higher prevalence of a patient/parent 
reported diagnosis of obstructive sleep apnea in those with intrapulmonary shunting (6/34 
(17.6%) vs. 6/109 (5.5%)) than in those without (p=0.036).  There were no differences, however, 
in patient/parent-reported snoring, asthma, diagnosis of pulmonary hypertension, or hemoglobin 
oxygen saturation.   
Discussion 
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We identified a high prevalence of potential right-to-left shunting in children with SCA and stroke 
compared to a control group of children without SCA or stroke. Potential right-to-left shunting 
was 2.7 times more likely in the children with SCA and stroke (95%CI 1.6-4.6).  The difference 
in prevalence of potential RLS between cases and controls appeared to be driven by higher 
prevalence of extra-cardiac, intrapulmonary shunts in cases with SCA and stroke.  Among 
children with SCA and stroke, those who had any potential RLS were almost twice as likely to 
recall having a headache at the onset of their stroke as children with SCA and stroke without 
potential RLS.  Intrapulmonary and intracardiac shunting could be an overlooked, independent, 
and potentially modifiable risk factor for stroke in children with SCA. 
Paradoxical embolization via patent foramen ovale is an established risk factor for stroke in 
young adults and children without SCA (Dowling and Ikemba, 2011; Ning, et al., 2013; Mattle, et 
al., 2010).  Meta-analysis of 15 studies showed that adult stroke patients were 1.69 times (CI 
1.40-2.06) more likely to have a PFO than non-stroke controls (Mattle, et al., 2010).  There are 
only limited studies of the prevalence of potential shunting in children with or without stroke 
(reviewed in Dowling and Ikemba, 2011).  In our pilot study (Dowling, et al., 2010) retrospective 
chart review found potential shunting in 11.7% (7/60) of children with stroke who did not have 
SCD (excluding children with known congenital heart disease).  Benedik and colleagues (2011) 
reported on transesophageal echocardiograms with contrast as well as using contrasted 
transcranial Doppler ultrasonography and reported potential shunting in 7/26 (27%) of controls 
compared with 11/23 (48%) of children with stroke or TIA (without SCD) excluding those with 
other identified aetiologies for stroke. Intrapulmonary shunting alone was an independent 
predictor of cryptogenic stroke or TIA in adults without SCA compared to controls (OR 2.6 (CI 
1.6-4.2)) (Abushora, et al., 2013). Prothrombotic states predispose to paradoxical embolization 
in adult patients with potential intracardiac shunting (Hassell, 2005; Giardini, et al., 2004; 
Karttunen, et al., 2003) and the Valsalva maneuver, which can increase right heart pressures 
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and favor right-to-left shunting, is common at the onset of stroke in adults without SCA 
(Karttunen, et al., 2003; Bogousslavsky, et al., 1996). 
There are several physiologic features of SCA that may serve to predispose to stroke by 
paradoxical embolization.  First, SCA is, in itself, characterized by activation of coagulation.  Old 
and new thrombi are observed in the pulmonary vasculature in postmortem studies of patients 
with SCA, illustrating the effective pulmonary filter.  SCA patients have been shown to have high 
levels of circulating thrombin, activation of fibrinolysis, decreased levels of anticoagulant 
proteins, and platelet activation (Ataga and Orringer, 2003; Shah, et al., 2012; Ataga, et al., 
2012; Colombatti, et al., 2013; Whelihan et al., 2014; Hyacinth, et al., 2015).  Further, right-to-
left shunting is favored in SCA given the pathophysiologic changes secondary to anemia and 
pulmonary venous or arterial hypertension, especially in the setting of acute chest syndrome.  
These conditions will raise right heart pressures, increasing the likelihood of right-to-left 
shunting and therefore potential for paradoxical embolization. 
Prior studies of fat embolization syndrome in SCA also support the role of paradoxical 
embolization in stroke in SCA.  Multiple scattered punctate MRI abnormalities, consistent with 
embolic phenomenon were reported in an SCA patient with fat embolization syndrome following 
vaso-occlusive crisis (Horton, et al., 1995).  Neurologic symptoms, including focal signs and 
focal lesions on MRI, were noted in half of the patients with fat emboli detected by 
bronchoscopy in patients with vaso-occlusive crisis and acute chest syndrome, while none of 
the patients without pulmonary fat emboli had neurologic symptoms (Vichinsky, et al., 1994). 
The heart was not examined in these studies, but the only route for fat emboli to the brain is via 
cardiac or pulmonary right-to-left shunting.  Indeed, fat emboli have been directly observed 
passing through a PFO during intraoperative echocardiogram in a patient without SCA 
undergoing surgical repair of a femoral fracture (Pell, et al., 1993).  
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The high prevalence of potential right-to-left shunting we identified in children with SCA and 
stroke, (45.6%) compared to that in our control group of children without SCA or stroke (23.6%) 
suggests that paradoxical embolization across an intracardiac or intrapulmonary shunt could be 
a risk factor for stroke in children with SCA.  However, this increased prevalence of potential 
RLS could be due to changes common to all children with SCA and not causally related to 
stroke in this group.  Further, the role of RLS in silent cerebral infarction is not known. We did 
not include children with silent cerebral infarction in this study.  It is possible that there could be 
an even greater contribution from shunting to silent cerebral infarction than overt stroke.  PFO 
has also been associated with silent cerebral infarction in adults without SCA (Clergeau, et al., 
2009; Ueno, et al., 2010). 
In a recent study of 29 SCA patients with first ischemic stroke in adulthood, 7/29 (24%) had 
cardiac embolism as an identified etiology for their stroke (Calvet, et al., 2015).  Large PFO was 
identified in 3 patients, dilated cardiomyopathy in 1 and fat embolism in another patient.  Stroke 
was attributed to vasculopathy in 12/29, antiphospholipid antibody syndrome in 1, and was 
undetermined in 8.  Only 22/29 of these adults with SCA and stroke had echocardiograms.  It 
was not reported if these were contrast studies.   Our data (Table 2) clearly demonstrate that 
the addition of IV contrast dramatically increases the detection rate for potential shunting.  As 
noted in studies of stroke in children without SCA, it is likely that individual patients have 
multiple stroke risk factors (Mackay, et al., 2011).  More thorough etiologic investigations may 
reveal their presence in children and adults with SCA and stroke and offer opportunities for 
prevention.    evaluate for OSA or nighttime hypoxaemia and most centres in this study did not, 
at the time of the study, evaluate their patients for OSA or nighttime hypoxaemia 
We did not observe an association of potential shunting with recurrent stroke or TIA in our 
study. However, one fifth of our SCA patients had their echocardiogram within 2 years of index 
stroke, with several enrolled at the time of initial stroke presentation.  This limited our ability to 
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detect a relationship between RLS and recurrent stroke.  In the previously mentioned study of 
adults with SCA and stroke, 9/29 had recurrent stroke which was attributed to cardiac embolism 
in 4 cases. (Calvet, et al., 2015).  In children with SCA, recurrent stroke is often attributed to 
moyamoya syndrome or progressive cerebral vasculopathy.  However, stroke recurrence, as 
well as first time stroke, still occurs in the absence of vasculopathy, albeit at a lower rate 
(Hulbert, et al., 2011).  In this subset of patients, paradoxical embolization may play a larger 
role, as appears to be the case in non-SCA childhood stroke, (Benedik, et al., 2007) and it must 
be noted that the presence of vasculopathy does not rule out paradoxical embolization as an 
etiology for stroke.  Unfortunately, due to budgetary constraints, we did not obtain vascular 
imaging as part of this study.    
Another important finding of this study is the high prevalence of intrapulmonary shunting in the 
SCA+stroke group.  Intrapulmonary shunting was only discernable by our method in participants 
without concomitant intracardiac shunting, which may have obscured some relevant clinical 
associations. A similar high prevalence of intrapulmonary RLS was reported in adults with SCA 
(16% vs. 3.8% in general medical patients without SCA) (Langer, et al., 2013).  Thus, this high 
prevalence of intrapulmonary shunting we observed may be common in children with SCA 
without stroke.  Our control group was limited to children without SCA or stroke.  Future studies 
of RLS in children with SCD without stroke are needed.  In an exploratory analysis, we found 
that prior diagnosis of obstructive sleep apnea (OSA) was associated with intrapulmonary 
shunting, but our patients were not systematically evaluated for OSA.  Intrapulmonary shunting 
was not associated with other indicators of lung disease or OSA such as patient reported 
snoring, asthma, diagnosis of pulmonary hypertension or low daytime hemoglobin oxygen 
saturation.  We were not funded for polysomnography or overnight oximetry and most centres in 
this study did not, at the time of the study, evaluate their patients for OSA or nighttime 
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hypoxaemia but exploration of the possible association between OSA and/or nighttime 
hypoxaemia and RLS would be of interest in future studies. 
Our study has several limitations.  Research ethics considerations in children precluded 
placement of an IV solely for research, limiting our ability to evaluate children with SCA without 
stroke who were not acutely ill and is why we assembled a control group of children without 
SCA or stroke who already had IV access obtained for another clinical indication.  The high 
prevalence of potential shunting we found could apply to all children with SCA, not just those 
with stroke.  It also could be a marker of more severe disease and warrants further 
investigation.  Future studies to compare the prevalence of potential RLS in children with SCA 
both with and without stroke or silent cerebral infarction are needed.  Our study does provide 
much needed control data (Dowling and Ikemba, 2011) on the prevalence of potential shunting 
by contrasted echocardiography in a large population of children without stroke or other 
neurologic indications for testing.  RLS is clearly not likely to be the only, or the major cause of 
stroke in children with SCA, but could be an important contributing etiology in some patients.   
Analysis of the contribution of concurrent illnesses, cerebral vasculopathy, and other potential 
stroke risk factors in this population is needed.   
There was a substantial time period between onset of stroke and our evaluation by 
echocardiogram in many patients (Table 1).  Autopsy studies show a decline in PFO prevalence 
with each decade, (Hagen, et al., 1984) so we may have underestimated the prevalence of 
intracardiac shunting at the time of stroke.  However, our analysis found that age was not a 
predictor of “any shunting” or “intrapulmonary shunting” in our study population.  We also did not 
statistically correct for multiple comparisons in our analysis of clinical and laboratory factors 
associated with shunting.  The one factor we found to be significantly associated with shunting, 
namely headache at the time stroke onset, was also found in our pilot study, (Dowling, et al., 
15 
 
2010) and intracardiac shunting has been associated with migraine in adults (Schwedt, et al., 
2008). 
There are clearly multiple independent risk factors for stroke in SCA, including vasculopathy, 
anemia (acute and chronic), and antecedent medical events, among others (Scothorn, et al., 
2002; Kirkham, 2007; Quinn and Sargent, 2008; Dowling et al., 2012). In our study we did not 
stratify patients by these etiologies and MRI/A data was not included in our primary analysis.  It 
is possible that shunting may have a pathologic role in specific stroke subtypes. Our 
observations, and recent studies in adults with SCA showing a high prevalence of cardioembolic 
etiologies for stroke (Calvet, et al., 2015) support paradoxical embolization via RLS as a 
possible cause of stroke in children with SCA.   
In summary, potential right-to-left shunting is common in children with SCA and stroke. We 
recommend that all children with SCA and stroke be evaluated by contrasted echocardiography, 
especially those who have headache at onset.   We propose that intracardiac and 
intrapulmonary right-to-left shunting is an overlooked, independent, and potentially modifiable 
risk factor for stroke in children with SCA.  In addition to chronic transfusion or hydroxyurea 
therapy, additional methods to prevent stroke, such as anti-platelet therapy, anticoagulation, or 
shunt closure, need to be studied in children with SCA. 
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Table 1   Subjects 
 SCA+Stroke  Control P value 
Age at Stroke Onset  
(mean yr ± SD) 
6.2 ± 3.8 - - 
Age at Echocardiogram  
(mean yr ± SD) 
12.7 ± 4.8 12.1 ± 4.9 0.326* 
Gender  
(% male) 
54.4 53.3 0.851* 
Race  Black   (%) 
           Caucasian 
           Asian 
           Other 
 99.3 
0   
0 
  0.7 
25.7 
64.6 
  4.4 
  5.3 
<0.001† 
*Student’s independent samples t-test.   †Fisher’s Exact test based on comparison of Black vs 
all others.  
 
 
 
 
Table 2   Prevalence of Potential Right-to-Left Shunt Detected in SCA+Stroke and Control 
Subjects 
Method of Shunt Detection 
SCA+Stroke 
# (%) 
Control 
# (%) 
P value* 
2-D Imaging 3/139 (2.2%) 0/122  (0%)   0.250† 
Color Doppler 9/139 (6.5%)   8/122  (6.6%) 0.978 
Contrast Injection without Valsalva 22/146 (15.1%)   19/122 (15.6%) 0.909 
Contrast Injection with Valsalva 24/145 (16.6%)   19/118 (16.1%) 0.922 
Potential Intracardiac Shunting 32/147 (21.8%)   23/123 (18.7%) 0.533 
Potential Intrapulmonary Shunting  
“Late Bubbles” only 
35/147 (23.8%)  7/123 (5.7%) <0.001 
Any Potential Shunting   
(Intracardiac or Intrapulmonary) 
67/147 (45.6%)   29/123 (23.6%) <0.001 
*Chi-square test, with Fisher’s exact where indicated† 
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Table 3   Clinical Factors Present in SCA+Stroke Patients with and without Potential 
Shunt 
Factor 
Any Shunt 
Absent 
# (%) 
Any Shunt 
Present 
# (%) 
P 
value* 
Age at Stroke Onset  (years, mean±SD) 5.9 ± 3.5 6.6 ± 4.2 0.286• 
Age at Echocardiogram  (years, mean±SD) 12.4 ± 4.7 13.1 ± 4.9 0.336• 
Gender (% male) 42/80 (52.5%) 38/67 (56.7%) 0.609* 
Acute Illness at Onset or 2w prior to stroke 42/77 (54.5%) 33/63 (52.4%) 0.798* 
TIA prior to onset   1/80  (1.3%)  2/67  (3.0%) 0.592† 
Headache at stroke presentation 17/63 (27.0%) 24/50 (48.0%) 0.021* 
Ongoing Headache or Migraine 28/79 (35.4%) 23/67 (34.3%) 0.888* 
Seizures (at presentation or subsequently) 19/80 (23.8%) 17/67 (25.4%) 0.820* 
Stroke Outcome, PSOM (median, range) 0.5 (0-8) 0.5 (0-8) 0.943‡ 
Recurrent Stroke or TIA 27/80 (33.8%) 21/67 (31.3%) 0.757* 
Hgb Oxygen Saturation (median, range) 99 (96-100) 99 (93-100) 0.310‡ 
Hx of Acute Chest Syndrome 34/73 (46.6%) 28/59 (47.5%) 0.920* 
Hx of frequent pain crises (> 5) 22/69 (31.9%) 17/59 (28.8%) 0.707* 
Hx of Gallstones 14/72 (19.4%) 10/54 (18.5%) 0.896* 
Hx of Priapism (for males) 3/38  (7.9%)  7/34 (20.6%) 0.175† 
Hx of Splenic Sequestration 13/72 (18.1%) 17/58 (29.3%) 0.130* 
Hx of Aplastic Crisis 6/70 (8.6%)    7/53  (13.2%) 0.408* 
Hx of Aseptic Necrosis 1/72 (1.4%)   3/59  (5.1%) 0.326† 
Dx of Pulmonary Hypertension 2/69 (2.9%)   2/60  (3.3%) >0.999† 
Hgb Conc at/prior to stroke (median, range) 7.95 (5.0-13.9) 8.05 (2.4-13.7) 0.972‡ 
WBC at/prior to stroke (x103, median, range) 15.52 (4.4-42.4) 14.21 (4.7-41.3) 0.359‡ 
Plt at/prior to stroke (x103, median, range) 351.5 (114-763) 395.0 (92-1091) 0.833‡ 
HgbS% at/prior to stroke (median, range) 57.8 (5-100) 60.5 (6.3-100) 0.607‡ 
Retics % at/prior to stroke (median, range) 13.6 (3-31.8) 11.1 (1-20.1) 0.702‡ 
Any Family Hx of Hypercoagulable State 34/78 (43.6%) 35/65 (53.8%) 0.222* 
Report of Snoring or Diagnosis of OSA 21/78 (26.9%) 22/67 (32.8%) 0.437* 
Asthma 25/79 (31.6%) 20/66 (30.3%) 0.862* 
•Student’s independent samples t-test, ‡Mann-Whitney U test, *Chi-square test, or †Fisher’s 
exact where indicated.    Abbreviations:  TIA= transient ischemic attack, WBC=white blood cell, 
Plt=Platelet, Retics = Reticulocytes, OSA= obstructive sleep apnea, Hx=History, Hgb= 
hemoglobin.  PSOM= Pedi Stroke Outcome Measure (0= no deficit, 10= severe deficit)  
 
